Data edition of
Residue An evidence-graded reference for peptide science

Kisspeptin-10 research

What PubMed holds on Kisspeptin-10, sorted by study design: the papers this site relies on, every clinical-trial publication PubMed tags, and the newest additions.

PubMed records
317
Trial publications
95 randomized
Reviews
13
Human-subject tagged
110
Animal-only
172
  • Clinical-trial publications 9
  • Reviews 13
  • Animal-only studies 172
  • Other (in vitro, chemistry, commentary, unindexed) 123
Figure 1. Composition of the Kisspeptin-10 literature by PubMed publication type and MeSH tags. Categories come from separate PubMed filters and can overlap; “animal-only” means tagged Animals and not Humans. Query: ("kisspeptin-10"[tiab] OR "kisspeptin 10"[tiab]).
01326 2004: 3 records 2004 2005: 7 records 2005 2006: 10 records 2007: 10 records 2008: 16 records 2009: 26 records 2010: 24 records 2010 2011: 19 records 2012: 14 records 2013: 15 records 2014: 19 records 2015: 14 records 2015 2016: 15 records 2017: 26 records 2018: 22 records 2019: 16 records 2020: 19 records 2020 2021: 13 records 2022: 20 records 2023: 11 records 2024: 10 records 2025: 21 records 2025 2026: 22 records (year to date) 2026
Figure 2. PubMed records per publication year matching ("kisspeptin-10"[tiab] OR "kisspeptin 10"[tiab]) — 317 in total; peak 26 in 2009. The 2026 bar is year-to-date (hatched). Volume of literature is not evidence of efficacy. Run this query on PubMed.

Studies this site relies on

Ordered by strength of design. Conclusions are quoted verbatim from each abstract as indexed by PubMed; read the full paper before relying on any of them.

  1. Randomized trial Eur J Endocrinol · 2026 PMID 42549827

    Chronic subcutaneous kisspeptin-10 stimulates gonadotropin secretion for 12 days in healthy men

    Yeung AC, Phylactou M, Koysombat K, et al.

    We demonstrate that chronic subcutaneous kisspeptin administration sustains gonadotropin and testosterone secretion in healthy men for 12 days. These data can inform development of chronic kisspeptin administration protocols for the treatment of reproductive disorders.

  2. Clinical trial Clin Endocrinol (Oxf) · 2013 PMID 23153270

    Exploring the pathophysiology of hypogonadism in men with type 2 diabetes: kisspeptin-10 stimulates serum testosterone and LH secretion in men with type 2 diabetes and mild biochemical hypogonadism

    George JT, Veldhuis JD, Tena-Sempere M, et al.

    Kisspeptin-10 administration increased LH pulse frequency and LH secretion in hypotestosteronaemic men with T2DM in this proof-of-concept study, with associated increases in serum testosterone. These data suggest a potential novel therapeutic role for kisspeptin agonists in enhancing endogenous testosterone secretion in men with T2DM and …

  3. Clinical trial J Clin Endocrinol Metab · 2011 PMID 21632807

    Kisspeptin-10 is a potent stimulator of LH and increases pulse frequency in men

    George JT, Veldhuis JD, Roseweir AK, et al.

    Kisspeptin-10 boluses potently evoke LH secretion in men, and continuous infusion increases testosterone, LH pulse frequency, and pulse size. Kisspeptin analogues have therapeutic potential as regulators of LH and thus testosterone secretion.

  4. Primary study J Endocr Soc · 2017 PMID 29264460

    Hypothalamic-Pituitary-Ovarian Axis Reactivation by Kisspeptin-10 in Hyperprolactinemic Women With Chronic Amenorrhea

    Millar RP, Sonigo C, Anderson RA, et al.

    In this exploratory study, we demonstrated that administration of Kp-10 reactivated gonadotropin secretion in women with hPRL-HA and increased ovarian activity. Our data suggest that, as in rodents, GnRH deficiency in hPRL-HA is also mediated by an impairment of hypothalamic Kp secretion. Kp-10 or its analogues could have therapeutic …

  5. Primary study Hum Reprod · 2012 PMID 22956346

    Kisspeptin-10 stimulation of gonadotrophin secretion in women is modulated by sex steroid feedback

    George JT, Anderson RA, Millar RP

    STUDY FUNDING: Medical Research Council (UK). COMPETING INTERESTS: None.

  6. Primary study J Clin Endocrinol Metab · 2011 PMID 21976724

    The effects of kisspeptin-10 on reproductive hormone release show sexual dimorphism in humans

    Jayasena CN, Nijher GM, Comninos AN, et al.

    Kisspeptin-10 stimulates gonadotropin release in men as well as women during the preovulatory phase of menstrual cycle but fails to stimulate gonadotropin release in women during the follicular phase. The sexual dimorphism of the responsiveness of healthy men and women to kisspeptin-10 administration has important clinical implications …

Clinical-trial publications in PubMed

9 records carry PubMed’s clinical-trial publication type. Tagging is done by NLM indexers and occasionally includes secondary analyses.

Newest records

The most recent PubMed additions for this query at the data-edition date, regardless of design.

← Back to the Kisspeptin-10 monograph B